Sarm1 Deletion, but Not WldS, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy

Jonathan Gilley, Richard R. Ribchester, Michael P. Coleman

Research output: Contribution to journalArticlepeer-review


Studies with the WldS mutant mouse have shown that axon and synapse pathology in several models of neurodegenerative diseases are mechanistically related to injury-induced axon degeneration (Wallerian degeneration). Crucially, an absence of SARM1 delays Wallerian degeneration as robustly as WldS, but their relative capacities to confer long-term protection against related, non-injury axonopathy and/or synaptopathy have not been directly compared. While Sarm1 deletion or WldS can rescue perinatal lethality and widespread Wallerian-like axonopathy in young NMNAT2-deficient mice, we report that an absence of SARM1 enables these mice to survive into old age with no overt phenotype, whereas those rescued by WldS invariantly develop a progressive neuromuscular defect in their hindlimbs from around 3 months of age. We therefore propose Sarm1 deletion as a more reliable tool than WldS for investigating Wallerian-like mechanisms in disease models and suggest that SARM1 blockade may have greater therapeutic potential than WLDS-related strategies.

Original languageEnglish
Pages (from-to)10-16
Number of pages7
JournalCell Reports
Issue number1
Publication statusPublished - 3 Oct 2017


  • Journal Article


Dive into the research topics of '<i>Sarm1</i> Deletion, but Not <i>Wld</i><sup>S</sup>, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy'. Together they form a unique fingerprint.

Cite this